Related references
Note: Only part of the references are listed.Synthesis and pharmacokinetic properties of novel cPLA2? inhibitors with 1-(carboxyalkylpyrrolyl)-3-aryloxypropan-2-one structure br
Angelina Subeska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2023)
Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
Maximilian Barth et al.
CHEMMEDCHEM (2022)
Contribution of cyclooxygenase-1-dependent prostacyclin synthesis to bradykinin-induced dermal extravasation
Michael Krybus et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases
Charikleia S. Batsika et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents
Jalal Soubhye et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A2α: Effect of substituents at the indole 3-position on activity, solubility, and metabolic stability
Martina Arnsmann et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Involvement of microsomal NADPH-cytochrome P450 reductase in metabolic reduction of drug ketones
Matthias Lehr et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2015)
Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure
Joerg Fabian et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Inhibition of benzalkonium chloride-induced skin inflammation in mice by an indol-1-ylpropan-2-one inhibitor of cytosolic phospholipase A2α
K. Roebrock et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Determination of arachidonic acid by on-line solid-phase extraction HPLC with UV detection for screening of cytosolic phospholipase A2α inhibitors
Walburga Hanekamp et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Differential Selectivity of Efflux Transporter Inhibitors in Caco-2 and MDCK-MDR1 Monolayers: A Strategy to Assess the Interaction of a New Chemical Entity with P-gp, BCRP, and MRP2
Kirsten Mease et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α with Reduced Lipophilicity: Synthesis, Biological Activity, Metabolic Stability, Solubility, Bioavailability, And Topical in Vivo Activity
Andreas Drews et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Indole cytosolic phospholipase A2 α inhibitors:: Discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib
John C. McKew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A2 based on a 1,3-disubstituted propan-2-one skeleton
S Connolly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)